Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

An unusually low prevalence of Huntington's disease in Iceland.

Sveinsson O, Halldórsson S, Olafsson E.

Eur Neurol. 2012;68(1):48-51. doi: 10.1159/000337680.

0

0

0

PUBMED

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH.

Hum Mol Genet. 2012 Jan 15;21(2):406-20. doi: 10.1093/hmg/ddr475.

0

0

0

PUBMED

N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.

Sandhir R, Sood A, Mehrotra A, Kamboj SS.

Neurodegener Dis. 2012;9(3):145-57. doi: 10.1159/000334273.

0

0

0

PUBMED

Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis.

Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, Silveira I, Ross CA, Margolis RL, Rudnicki DD.

Ann Neurol. 2012 Feb;71(2):245-57. doi: 10.1002/ana.22598.

0

0

0

PUBMED

Medical marijuana in Huntington's disease: report of two cases.

Meisel K, Friedman JH.

Med Health R I. 2012 Jun;95(6):178-9. No abstract available.

0

0

0

PUBMED

Language impairment in Huntington's disease.

Azambuja MJ, Radanovic M, Haddad MS, Adda CC, Barbosa ER, Mansur LL.

Arq Neuropsiquiatr. 2012 Jun;70(6):410-5.

0

0

0

PUBMED

pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.

Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V.

J Cereb Blood Flow Metab. 2012 May;32(5):771-9. doi: 10.1038/jcbfm.2012.15.

0

0

0

PUBMED

Clinical and genetic characteristics in patients with Huntington's Disease from Argentina.

Gatto E, Parisi V, Persi G, Converso DP, Etcheverry JL, Varela V, Lopez A, Alba L, Fretchel G.

Parkinsonism Relat Disord. 2012 Feb;18(2):166-9. doi: 10.1016/j.parkreldis.2011.09.011. Erratum in: Parkinsonism Relat Disord. 2014 Jan;20(1):136. Lopez, Ariel [added].

0

0

0

PUBMED

Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease.

Mori F, Tanji K, Toyoshima Y, Yoshida M, Kakita A, Takahashi H, Wakabayashi K.

Acta Neuropathol. 2012 May;123(5):747-9. doi: 10.1007/s00401-012-0956-x. No abstract available.

0

0

0

PUBMED

The impact of different types of assistive devices on gait measures and safety in Huntington's disease.

Kloos AD, Kegelmeyer DA, White SE, Kostyk SK.

PLoS One. 2012;7(2):e30903. doi: 10.1371/journal.pone.0030903.

0

0

0

PUBMED

Mutation in the CHAC gene in a family of autosomal dominant chorea-acanthocytosis.

Walker RH, Velayos-Baeza A, Bader B, Danek A, Saiki S.

Neurology. 2012 Jul 10;79(2):198-9; author reply 199. doi: 10.1212/01.wnl.0000416389.94466.01. No abstract available.

0

0

0

PUBMED

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.

Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H.

Mol Brain. 2012 May 21;5:17. doi: 10.1186/1756-6606-5-17.

0

0

0

PUBMED

Making sense out of antisense in Huntington's disease.

Skaper SD.

CNS Neurol Disord Drug Targets. 2012 Sep;11(6):647-8. No abstract available.

0

0

0

PUBMED

Effect of tetrabenazine on motor function in patients with huntington disease.

Ferrara JM, Mostile G, Hunter C, Adam OR, Jankovic J.

Neurol Ther. 2012 Sep 29;1(1):5. doi: 10.1007/s40120-012-0005-7.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy